Breakthrough drug could give sensitized kids a second chance at kidney transplant
NCT ID NCT05753930
First seen May 01, 2026 · Last updated Jun 16, 2026 · Updated 5 times
Summary
This study tests a drug called imlifidase in 10 highly sensitized children aged 1-17 who need a kidney transplant. These children have antibodies that make it hard to find a matching donor. The drug aims to quickly clear those antibodies so the transplant can happen. After the transplant, children will take standard anti-rejection medicines to keep the new kidney working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION IN HIGHLY SENSITIZED PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Great Ormond Street Hospital for Children NHS Foundation Trust
RECRUITINGLondon, WC1N 3JH, United Kingdom
Contact
Contact
-
HUS, Helsinki University Hospital
WITHDRAWNHelsinki, 00290, Finland
-
Hospital Unviersitari Vall d'Hebron, Nefrología Pediátrica
RECRUITINGBarcelona, 08035, Spain
Contact Email: •••••@•••••
Contact
-
Karolinska University Hospital
RECRUITINGHuddinge, Stockholm County, SE-141 86, Sweden
Contact Email: •••••@•••••
Contact
-
Robert Debre University Hospital
RECRUITINGParis, 75019, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.